We offer PROTAC linker synthesis that connects ligands for E3 ligases and target proteins, supporting the emerging field of protein degradation therapeutics.
Key Highlights:
Flexible linker design and optimization
Rapid synthesis and analytical verification
Scalable production for early and late-stage research
Our expertise ensures each PROTAC construct maintains structural balance and bioactivity.